马凡综合征伴晶状体异位患者行巩膜隧道内眼内晶状体固定术并保留前部玻璃体界面。
Transscleral intraocular lens fixation with preservation of the anterior vitreous face in patients with marfan syndrome and ectopia lentis.
机构信息
From the Department of Ophthalmology, Haeundae Paik Hospital, Inje University, Busan, South Korea; and Department of Ophthalmology, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, South Korea.
出版信息
Cornea. 2010 Nov;29 Suppl 1:S20-4. doi: 10.1097/ICO.0b013e3181ea48de.
PURPOSE
To evaluate the safety and efficacy of transscleral intraocular lens fixation with preservation of the anterior vitreous in the treatment of ectopia lentis in patients with Marfan syndrome.
METHODS
Patients who had undergone surgical intervention for ectopia lentis with or without lenticular opacity were included. Best-corrected visual acuity before and after surgery was compared. Perioperative complications were evaluated.
RESULTS
A total of 23 patients (45 eyes) whose mean age at surgery was 16.9 ± 8.9 years were recruited. The mean follow-up period was 10.1 ± 5.8 months. Mean best-corrected visual acuity change (with respect to preoperative logarithm of the minimum angle of resolution value) was 1.03 ± 0.39. All patients showed >2 lines of improvement in visual acuity. Pupillary capture was found in 6 eyes. Medically controllable intraocular pressure elevation was noted in 12 eyes.
CONCLUSION
Transscleral intraocular lens fixation with preservation of the anterior vitreous face is a safe and effective technique for treatment of ectopia lentis in patients with Marfan syndrome.
目的
评估保留前玻璃体的经巩膜眼内晶状体固定术治疗马凡综合征患者晶状体异位的安全性和有效性。
方法
纳入接受晶状体异位手术治疗的患者，包括伴或不伴晶状体混浊的患者。比较手术前后的最佳矫正视力。评估围手术期并发症。
结果
共纳入 23 名（45 只眼）年龄 16.9 ± 8.9 岁的患者。平均随访时间为 10.1 ± 5.8 个月。平均最佳矫正视力变化（相对于术前最小分辨角对数视力值）为 1.03 ± 0.39。所有患者的视力均提高了>2 行。6 只眼出现瞳孔捕获。12 只眼出现可通过药物控制的眼压升高。
结论
保留前玻璃体的经巩膜眼内晶状体固定术是治疗马凡综合征患者晶状体异位的一种安全有效的方法。
Zotero 插件